Cystic fibrosis year in review 2019: Section 2 pulmonary disease and infections

Pediatr Pulmonol. 2023 Mar;58(3):672-682. doi: 10.1002/ppul.25091. Epub 2020 Sep 30.

Abstract

During the year 2019, research and case reports or series in the field of cystic fibrosis (CF) were in abundance. To adequately address the large body of CF research published during 2019, the CF year in review will be divided into three sections. This report is the second section, focusing specifically on new research related to pulmonary disease and infections. Additional sections will concentrate on CF transmembrane conductance regulator modulators and the multisystem effects of CF. It is an exciting time to be providing care for patients and their families with CF with all the exciting new discoveries that will be shared in these reviews.

Keywords: cystic fibrosis; imaging; pulmonology.

Publication types

  • Review

MeSH terms

  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics
  • Cystic Fibrosis Transmembrane Conductance Regulator / metabolism
  • Cystic Fibrosis* / complications
  • Humans
  • Signal Transduction

Substances

  • Cystic Fibrosis Transmembrane Conductance Regulator